Presepsin test for diagnosing sepsis in newborns
Part of Genetic & congenital, Infections clinical trials.
This study looks at whether a blood test called presepsin can help doctors diagnose sepsis (a serious infection) in newborn babies. If it works, it could help doctors start treatment faster and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be less than 1 month old
- Your baby must have signs of infection or risk factors for sepsis, such as prolonged labor or fever during delivery
- Your baby must not have received antibiotics before being admitted to the hospital
- Your baby must not have birth asphyxia (lack of oxygen at birth) or certain birth defects
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two simple blood tests (CBC and lactate) in newborns with signs of infection. These tests may help doctors find sepsis faster and guide treatment.
This study tests whether adding N-acetylcysteine (NAC) to standard care helps newborns with sepsis recover better. Sepsis is a serious infection in the blood. NAC may reduce inflammation and improve outcomes.
This study uses a special ultrasound to see how sepsis, a severe infection, affects the heart's function in newborns. It compares newborns with sepsis to healthy newborns to understand the impact and help improve care.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
This study tests a blood test called presepsin to see how well it detects sepsis in people with severe burns. If you have burns covering at least 20% of your body and your doctor suspects sepsis, this trial may help improve early diagnosis and treatment.
Hear when a new Neonatal Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.